Cancers (Jan 2022)

The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease

  • Sebastian Krug,
  • Maryam Khosravian,
  • Julia Weissbach,
  • Katharina George,
  • Marko Damm,
  • Jakob Garbe,
  • Jens Walldorf,
  • Philipp A. Reuken,
  • Tania Amin,
  • Alexander Siebenhüner,
  • Jonas Rosendahl,
  • Thomas M. Gress,
  • Patrick Michl,
  • Jörg Schrader,
  • Anja Rinke

DOI
https://doi.org/10.3390/cancers14030613
Journal volume & issue
Vol. 14, no. 3
p. 613

Abstract

Read online

The assessment of cancer patient care during the COVID-19 pandemic has been mainly reported from a physician’s perspective. Patients with rare tumor entities such as neuroendocrine tumors (NET), which require a complex and specialized care infrastructure, were highly affected by the COVID-19 crisis. Using a structured questionnaire consisting of a general section on the disease and a special COVID-19 section to record medical care, vaccination behavior as well as social and psycho-emotional parameters were collected from NET patients. The survey was distributed via direct medical contact and via the patient organization NETZWERK NeT. A total of 684 patients participated in the survey and 79.2% (n = 542) of the participants answered the questionnaire completely (54 questions). Patient characteristics were comparable to those in large NET registries. The majority of participants were patients with pancreatic and small bowel NET on somatostatin analogue (SSA) therapy. Medical care under COVID-19 was adequate and appointment cancellations and postponements were not common. Nevertheless, the majority of patients were worried about adequate treatment for their tumor disease during the crisis. Most of the participants considered themselves to be at risk of severe COVID-19 infection and were therefore very concerned. This was accompanied by an extremely high vaccination readiness rate of 90%. Increased distress in the social and psycho-emotional domains in the course of the crisis reflected a need for optimization in the medical care of NET patients, although the rate of COVID-19 positive participants was low (3.7%). Therefore, patient-reported measurements are required to identify and address all areas of medical care. Overall, our survey provides an essential contribution to the care of NET patients during the COVID-19 pandemic from the patient’s perspective.

Keywords